Suchergebnisse - "Vermeire, S"

PubPharm (26)

1

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Dreesen, E. | Van Stappen, T. | Ballet, V. | +8

CommentIn: Aliment Pharmacol Ther. 2018 Mar;47(6):845-846. - PMID 29446128

2

Vedolizumab exposure in pregnancy : outcomes from clinical studies in inflammatory bowel disease

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentIn: Aliment Pharmacol Ther. 2017 May;45(9):1284. - PMID 28370036

3

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

enthalten in: Gastroenterology | 2016

von Regueiro, M. | Feagan, B. | Zou, B. | +115

CommentIn: Gastroenterology. 2016 Jun;150(7):1521-1524. - PMID 27138979

4

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2 : Current management (Spanish version)

enthalten in: Revista de gastroenterologia de Mexico | 2015

von Dignass, A. | Lindsay, J. | Sturm, A. | +14

5

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) : position document of the Belgian IBD Research & Development Group (BIRD)

enthalten in: Acta gastro-enterologica Belgica | 2015

von Vermeire, S. | Louis, E. | Dewit, O. | +9

6

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

enthalten in: Acta gastro-enterologica Belgica | 2012

von De Greef, E. | Hoffman, I. | D'Haens, G. | +20

7

Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis : a placebo-controlled crossover study

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2012

von Van Assche, G. | Ferrante, M. | Vermeire, S. | +7

8

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies

enthalten in: Alimentary pharmacology & therapeutics | 2010

von Allez, M. | Vermeire, S. | Mozziconacci, N. | +14

9

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

enthalten in: Gut | 2009

von Arijs, I. | Li, K. | Toedter, G. | +18

CommentIn: Gastroenterology. 2011 Feb;140(2):729-31. - PMID 21182960

10

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease : results from a single-centre cohort

enthalten in: Gut | 2009

von Schnitzler, F. | Fidder, H. | Ferrante, M. | +7

CommentIn: Gut. 2009 Apr;58(4):477-8. - PMID 19299379